InnovAge Announces Launch of Proposed Secondary Offering of Common Stock by Selling Stockholders

Go back to InnovAge Announces Launch of Proposed Secondary Offering of Common Stock by Selling Stockholders
Innovus Pharmaceuticals, Inc. (NASDAQ: INNV) Delayed: 9.28 +0.13 (1.42%)
Previous Close $9.15    52 Week High $0.66 
Open $9.17    52 Week Low $0.03 
Day High $9.29    P/E N/A 
Day Low $9.04    EPS $-0.20 
Volume 189,082